These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2181163)

  • 21. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
    Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
    Gotschuli A; Anderhuber W; Danninger R; Habermann W
    Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.
    Molina R; Torres MD; Moragas M; Filella X; Jo J; Giménez N; Traserra J; Ballesta AM
    Anticancer Res; 1995; 15(2):479-84. PubMed ID: 7763026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The monitoring of gynecological radiotherapy using serial tumor marker determinations].
    Wagner RK; Atzinger A; Breit A
    Strahlenther Onkol; 1990 Jul; 166(7):446-52. PubMed ID: 2200151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma].
    Hirata S; Yamazaki K; Yokoyama Y; Ueda M; Kubo Y; Samejima N
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):267-72. PubMed ID: 2747608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
    Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
    Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
    Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor cell death as reflected by the SCC-antigen level?].
    Clasen BP; Péré P; Senekowitsch R; Menz E
    Laryngorhinootologie; 1991 May; 70(5):250-4. PubMed ID: 2064701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
    Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T
    Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
    Meier W; Stieber P; Hasholzner U; Baumgartner L; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2959-62. PubMed ID: 9329575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):387-96. PubMed ID: 1870566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
    Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
    Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.